Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 18.85
+0.45 (2.45%)
At close: Nov 4, 2026
Vistin Pharma ASA Financials Overview
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 431.55 | 452.29 | 429.5 | 438.33 | 304.85 | 278.62 |
Revenue Growth | -5.20% | 5.31% | -2.01% | 43.78% | 9.41% | 9.74% |
Gross Profit Gross Profit Growth | 279.49 | 300.78 | 279.53 | 261.68 | 166.79 | 182.53 |
Operating Income Operating Income Growth | 71.36 | 92.35 | 85.3 | 68.6 | -6.1 | 33.25 |
Net Income Net Income Growth | 62.63 | 74.75 | 62.75 | 45.6 | -4.72 | 24.87 |
Earnings Per Share EPS Growth | 1.41 | 1.69 | 1.42 | 1.03 | -0.11 | 0.56 |
EPS Growth | -19.77% | 19.13% | 37.62% | - | - | - |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Africa Africa Growth | 49.64 | 42.91 | 65.7 | 37.48 | 57.93 |
Europe Europe Growth | 358.27 | 348.82 | 338.87 | 195.98 | 170.4 |
Asia Asia Growth | 41.05 | 32.99 | 29.32 | 19.8 | 23.74 |
North and South America North and South America Growth | 3.33 | 4.38 | 1.51 | 34.42 | 23.74 |
Total Total Growth | 452.29 | 429.09 | 435.39 | 287.68 | 275.81 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 22.04 | 16.42 | 12.8 | 26.2 | 1.44 | 35.75 |
Total Debt Total Debt Growth | 0.03 | 1.51 | 2.24 | - | 49.17 | 1.39 |
Net Cash (Debt) Net Cash Growth | 22.02 | 14.91 | 10.55 | 26.2 | -47.73 | 34.36 |
Net Cash Growth | - | 41.28% | -59.73% | - | - | -55.40% |
Net Cash Per Share Net Cash Per Share Growth | 0.50 | 0.34 | 0.24 | 0.59 | -1.08 | 0.77 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 103.04 | 78.04 | 107.86 | 90.59 | -10.51 | 13.68 |
Capital Expenditures CapEx Growth | -17.25 | -16.68 | -40.8 | -17.9 | -64.29 | -31.94 |
Free Cash Flow Free Cash Flow Growth | 85.8 | 61.35 | 67.05 | 72.69 | -74.8 | -18.26 |
Free Cash Flow Growth | 32.19% | -8.50% | -7.75% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.77% | 66.50% | 65.08% | 59.70% | 54.71% | 65.51% |
Operating Margin | 16.54% | 20.42% | 19.86% | 15.65% | -2.00% | 11.93% |
Pretax Margin | 18.38% | 21.19% | 18.73% | 13.35% | -1.97% | 11.48% |
Profit Margin | 14.51% | 16.53% | 14.61% | 10.40% | -1.55% | 8.92% |
FCF Margin | 19.88% | 13.56% | 15.61% | 16.58% | -24.54% | -6.55% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.500 | 1.500 | 1.250 | 1.000 | 0.750 | 0.750 |
Dividend Per Share Growth | 0% | 20.00% | 25.00% | 33.33% | 0% | 50.00% |
Dividend Yield | 7.96% | 7.21% | 5.27% | 4.29% | 4.75% | 3.87% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.35 | 12.34 | 16.75 | 22.66 | - | 34.56 |
Forward PE | - | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 |
P/FCF Ratio | 9.51 | 15.03 | 15.67 | 14.21 | - | - |
PS Ratio | 1.89 | 2.04 | 2.45 | 2.36 | 2.30 | 3.08 |